Global Scar Treatment Market - 2023-2030

Market Overview

The global scar treatment market size was valued at US$ 24 billion in 2022 and is estimated to reach US$ 32 billion by 2030, growing at a CAGR of 9.8% during the forecast period (2023-2030).

Skin is a continuous organ that is a delicate covering for priceless possessions. Think of a silky material. Even a tiny rip can have a significant impact on how it appears. The same holds for the skin. A scar might result after a burn, an injury, or another trauma, such as surgery. A scar is okay if it's minor or in a place where it can be covered up easily. Whether it's not, though, you might ask if there is a technique to cure it that will either make it disappear or, at the very least, alter how it appears, other than hiding it under clothing. The scar won't ever totally disappear, in actuality. However, various techniques can be used to lessen its size and alter its look.

Market Dynamics

The major factors driving the global scar treatment market the the demand for scar therapy is increasing due to scars from accidents, and other causes, one of the main factors propelling the growth of the global scar treatment market is a concern for aesthetic appearances. An increase in the prevalence of skin conditions and public awareness of scar treatment is driving the market.

The demand for scar therapy is increasing due to scars from accidents and other causes that are expected to drive the market's growth.

The major factor driving the demand for scar treatment solutions is increased traffic accidents. According to World Health Organization 2022, road traffic accidents claim the lives of about 1.3 million people yearly. There are an additional 20 to 50 million people who sustain non-fatal injuries, many of whom go on to develop disabilities.

Road traffic accidents result in significant economic damage for victims, their families, and entire countries. These costs result from the price of medical care, lost wages for individuals who are killed or rendered incapacitated by their injuries, and caregiving expenses for family members who must take time off from work or school to look after the injured. Most nations lose 3% of their gross domestic product to road accidents. Additionally, people who undergo such procedures experience surgical scarring and are given topical medications to lessen and conceal it. Consequently, the demand for topical scar therapy solutions is anticipated to increase due to the rising number of traffic accidents and aesthetic procedures.

One of the top five most often performed reconstruction procedures in 2019 was scar revision, according to the Plastic Surgery Statistics Report, which recorded 181,132 treatments. Therefore, the need for better aesthetic appeal contributes significantly to the rise in reconstructive surgery cases involving the removal of scars. Scar therapy solutions are also extensively used in addition to skin-correction operations.

Expensive cost is expected to hamper the market's growth.

However, the big hurdle to the market for scar therapy is the high cost of laser-based devices.

COVID-19 Impact Analysis

The COVID-19 epidemic significantly impacted the market for scar treatment. The e-commerce sector dramatically increased during the epidemic, and individuals began depending more on online cosmetics purchases. This made it easier for the scar treatment market's online customers to keep up with the pandemic. However, the overall sale of products for treating scars drastically decreased in hospitals and retail drug stores.

Additionally, because of the lockdown in major nations, fewer people traveled in 2020-2021, which decreased the frequency of vehicle accidents and the resulting injuries. As a result, it is noted that the COVID-19 pandemic has caused a large reduction in the value of the scar therapy business. However, it is anticipated that the market will pick up speed quickly in the short term now that the pandemic has been contained and all healthcare services have resumed.

Segment Analysis

The hospital animal segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The end user segment is the highest market holder in the global scar treatment market. By controlling the largest revenue shares in the global market, the hospital sector of the wound treatment industry generates the most money. In these hospital settings, the availability of modern infrastructure and technologically advanced items contributes to the market's dominance. Due to the widespread availability of scar therapy in hospitals, patients can choose from various treatments to lessen or completely remove the lesion. Hospitals typically provide patients with primary emergency care for burns, deep wounds, and other serious wounds.

For instance, according to National Fire Protection Association, in 2021, 1,353,500 fires resulted in 3,800 civilian deaths and 14,700 injuries. Despite a 42% decline in fire-related deaths since 1980, there will be 33% more in 2021 than in 2012, which was the lowest number of deaths reported by the NFPA (2,855). The 3,800 civilian fire fatalities in 2021 represent an 8.6% increase over the 3,500 number in 2020. The graph below demonstrates how hospital admissions and home fires accounted for most of these fatalities.

Hospitals also make the procedure available to patients to lessen the development of further marks on their bodies. Hospitals also feature a variety of technologically sophisticated practices and new equipment for better patient care. Hospitals typically use non-invasive therapies like silicone sheets, lotions, gels, and laser therapy. As a result, the numerous benefits the hospitals provide significantly contribute to segment growth.

Geographical Analysis

North America holds the largest market share in the global Scar Treatment market.

North America dominates the global scar treatment market primarily due to the high level of aesthetic concern among consumers and the quick uptake of cutting-edge products, North America dominated the market with a revenue share of 35.2% in 2020. Additionally, the United States has a big market for sophisticated laser devices for scar treatment.

In 2020, the U.S. held the biggest market share in North America. The American Burn Association (ABA) estimates that 486,000 burn cases occur yearly. In the United States, government reimbursement regulations support scar therapy resulting from burn injuries. Before a healthcare provider provides a Letter of Medical Necessity, scar therapy for acne may not be covered. Another significant factor influencing the American market is rising patient healthcare expenditures. The elements mentioned above will likely result in good growth for the scar treatment industry in the United States. Some key American market companies include Sonoma Pharmaceuticals, Cynosure, Inc., CCA Industries, Inc., and Scar Heal, Inc.

Numerous scar therapy products are covered by insurance in North America. A product submission differs depending on the types of scars and available treatments specified for the insurance codes. However, because laser therapy is seen as a cosmetic operation, most insurance companies do not pay the cost of the procedure. Cosmetic dermatology procedures include several popular scar-removal techniques, such as punch excision, skin needling, and soft tissue augmentation fillers.

Competitive Landscape

The Scar Treatment market is moderately competitive with local and global companies' presence TorquePharma Pvt. Ltd, Bausch Health, Asclepion Laser Technologies GmbH, Merz Pharma GmbH & Co. KGaA, Biodermis, Absolute MS (S) Pte Ltd., Avita Medical Limited, Scarguard Labs LLC, Z-ROC Dermatology, Perrigo Company Plc and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 2020, ARAZLO lotion, which is helpful in the treatment of scars from the elimination of acne, whiteheads, and blackheads, was launched by Bausch Health in the US.

Bausch Health.

Overview: A variety of pharmaceutical, over-the-counter (OTC), and medical device products are produced, developed, and marketed by Bausch Health Companies Inc (Bausch Health), previously Valeant Pharmaceuticals International Inc. Products for therapy relating to dermatology, gastrointestinal, eye health, neurology, aesthetic devices, dentistry, and consumer health are available from Bausch Health. It provides a range of branded generic and generic products. There are administrative, research and laboratory, marketing, distribution, and storage sites used by Bausch Health all throughout the world.

Product Portfolio:

ALTRENO (tretinoin) Lotion, 0.05%: Altreno (tretinoin) Lotion, 0.05% is a prescription medicine used on the skin (topical) to treat people with acne (blackheads, whiteheads, and other pimples). It is not known if Altreno is safe and effective in children under 9 years of age. Altreno is for use on the skin only.

The global scar treatment market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.